1-Methyl-4-nitroimidazole,
3034-41-1,
1-Methyl-4-nitro-1H-imidazole,
1H-Imidazole, 1-methyl-4-nitro-,
Imidazole, 1-methyl-4-nitro-,
BRN 0123533,
UNII-Z31100A55O,
AI3-51824,
CHEBI:80615,
HSCOLDQJZRZQMV-UHFFFAOYSA-N,
Z31100A55O,
3-methyl-5-nitroimidazole,
AC1L2BK9,
5-23-04-00486 (Beilstein Handbook Reference),
SCHEMBL174098,
AMOT0357,
CHEMBL3544543,
CTK8C3844,
DTXSID50184425,
ACN-P001082,
KS-00000I7G,
ZERO/000248,
ZINC1063081,
ANW-70655,
CL2229,
MFCD00159683,
QC-879,
SBB001538,
STK760074,
AKOS000601578,
ACN-001082,
AM85708,
CS-W018929,
MCULE-4199906753,
1-Methyl-4-nitro-1H-imidazole (9CI),
NCGC00340396-01,
1-Methyl-4-nitro-3-azonia-1H-imidazole,
AC-23143,
AJ-24835,
AK-77403,
BAS 00291728,
CJ-04704,
DS-17161,
LS-78790,
SC-49179,
ST069265,
SY041755,
AB0051006,
DB-068272,
TC-159400,
4CH-001651,
EU-0052121,
FT-0698197,
ST24027129,
Z4579,
MFCD00159683 (98%),
C16621,
M-9739,
AB01332166-02,
I14-13291,
(3R,4S)-Tofacitinib,
C4H5N3O2,
C4-H5-N3-O2,
CID18209,
N/A,